Zoono CEO quits as financial woes mount

Zoono CEO quits as financial woes mount
Zoono's antiviral solution got some heavy use through the pandemic. (Image: Getty)
Denise McNabb
Zoono Group’s chief executive, Barry Woolcott, has resigned seven months into the job. He will leave the troubled New Zealand-based and Australian stock exchange (ASX) listed manufacturer of a proprietary long-life hand and surface sanitiser in January.His departure follows a review of the company’s overhead structure after Zoono reported an annual loss of $12.1 million for the June 2022 year and negative net operating cashflow of $2m in the first quarter to Sept 30. Administration and corporate costs of $1.5m exceeded cus...

More Markets

Bulls, bears and analysis …
Opinion

Simon Robertson: Bulls, bears and analysis …

Why price-to-earnings ratios don’t cut it.

Simon Robertson 15 Nov 2025
NZ stocks take Wall Street lead to end down 1%
Markets Market Close

NZ stocks take Wall Street lead to end down 1%

The S&P/NZX 50 Index closed down 133.41 points or 0.98% at 13,464.46.

Jamie Gray 14 Nov 2025
Zoono says it knows no reason for share price surge, halt lifted
Markets

Zoono says it knows no reason for share price surge, halt lifted

A trading halt granted by the ASX to Australian-listed New Zealand antimicrobials manufacturer Zoono on Wednesday after a price query has been lifted after the company said it knew of no reason for its share price soaring.Its share price rose from 0.09c to 0.18c on volumes much h...

Denise McNabb 14 Nov 2025